Although it is possible to prevent ARMS metastasis by downregulating PAX3-FKHR, transcription factors are challenging drug targets, and currently there is no pharmacologic inhibitor of PAX3-FKHR available. The gene discussed is PAX3; the disease is alveolar rhabdomyosarcoma.